[1]
Feng, Y. et al. 2024. Research Progress on Multiple Effects and Clinical Application of Proprotein Convertase Subtilisin-kexin9 Inhibitors. Journal of Medical and Health Studies. 5, 2 (Apr. 2024), 54–58. DOI:https://doi.org/10.32996/jmhs.2024.5.2.6.